Crossmark

Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis

Crossref DOI link: https://doi.org/10.1186/s13075-017-1288-y

Published Online: 2017-04-26

Published Print: 2017-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Andrés Cerezo, Lucie https://orcid.org/0000-0003-1664-5834
Šumová, Barbora

Prajzlerová, Klára

Veigl, David

Damgaard, Dres

Nielsen, Claus Henrik

Pavelka, Karel

Vencovský, Jiří

Šenolt, Ladislav
Funding

Funding for this research was provided by:

Agency for Healthcare Research of the Czech Republic (15-34065A)

Ministerstvo Zdravotnictví Ceské Republiky (023728)